Back to top
more

Tenet Healthcare (THC)

(Delayed Data from NYSE)

$151.63 USD

151.63
1,459,243

+1.89 (1.26%)

Updated Jul 26, 2024 04:00 PM ET

After-Market: $151.64 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 1% (3 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Mednax (MD) Invests in Brave Care to Boost Pediatric Business

by Zacks Equity Research

Mednax (MD) and Brave Care form a relationship to provide enhanced pediatric care and pursue its pipeline of pediatric clinics' plan.

UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest

by Zacks Equity Research

UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.

Teladoc (TDOC) Broadens Accessibility of Primary Care Model

by Zacks Equity Research

Teladoc Health (TDOC) intends to offer enhanced primary care to its members through Primary360, whose reach has now extended to commercial health plans and employers.

Here's Why You Should Retain MEDNAX (MD) in Your Portfolio

by Zacks Equity Research

Riding high on its revenue stream and strategic measures, MEDNAX (MD) holds potential to reap benefits for investors.

Here's Why You Should Buy Acadia Healthcare (ACHC) Stock Now

by Zacks Equity Research

Acadia Healthcare (ACHC) continues to gain from top-line growth, solid demand for behavioral health services, several growth-related initiatives and reducing debt levels.

Is Tenet Healthcare (THC) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Srijita Guha headshot

3 Hospital Stocks That Outperformed the S&P Index Year to Date

by Srijita Guha

High patient volumes, mergers and buyouts and demand for virtual health services are likely to help hospital companies like THC, HCA and CYH outperform the S&P Index.

Here's Why You Should Hold Onto Select Medical (SEM) Now

by Zacks Equity Research

Select Medical (SEM) is a long-term player on the back of its leadership position in acute care services.

Tenet Healthcare (THC) Expands Its Relationship With Cigna

by Zacks Equity Research

Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.

Cigna (CI) Extends Tie-Up to Offer Better Care in Connecticut

by Zacks Equity Research

Cigna (CI) extends relationship with Hartford HealthCare to jointly offer enhanced healthcare services and thus, better health outcomes in Connecticut.

Tenet Healthcare (THC) Hits 52-Week High: More Upside Left? (Revised)

by Zacks Equity Research

Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it achieve its rally.

Here's Why Tenet Healthcare (THC) is a Strong Growth Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Universal Health Services, Acadia Healthcare Co, HCA Healthcare and Tenet Healthcare

Tenet Healthcare (THC) Hits 52 Week High: More Upside Left?

by Zacks Equity Research

Tenet Healthcare's (THC) enhanced portfolio, strategic initiatives and rebounding volumes help it aid its upsurge.

Debasmita Chatterjee headshot

4 Hospital Stocks Likely to Perform Well in 2H21

by Debasmita Chatterjee

Companies like UHS, ACHC, HCA and THC are well-poised to gain in the second half of 2021 as the hospital industry is expected to benefit from rebounding admissions and continuous M&A activities.

Why Is Tenet (THC) Down 0.8% Since Last Earnings Report?

by Zacks Equity Research

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain UnitedHealth Group (UNH) Stock

by Zacks Equity Research

UnitedHealth Group (UNH) gains from improved revenues stemming from strong segmental performances, expansion of service offerings and a strong cash balance.

Tenet Healthcare (THC) Announces Partial Redemption of Notes

by Zacks Equity Research

To boost financial flexibility, Tenet Healthcare (THC) announces partial redemption of senior secured notes to procure funds for paying down its future annual cash interest payments.

7 Reasons Why Select Medical (SEM) Stock Looks Attractive

by Zacks Equity Research

Select Medical (SEM) looks a profitable investment bet on the back of its top-line growth, backed by a solid financial position as well as acquisitions and joint ventures.

Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

MEDNAX's (MD) Earnings Beat Estimates in Q2, Improve Y/Y

by Zacks Equity Research

MEDNAX's (MD) Q2 results reflect solid volumes, partly offset by escalating expenses.

Magellan (MGLN) Q2 Earnings Decline Y/Y on High Expenses

by Zacks Equity Research

Magellan Health's (MGLN) second-quarter results dampened by escalating expenses, partly offset by growth in revenues and Healthcare segment.

Sapna Bagaria headshot

3 Hospital Stocks to Buy as the Top-Ranked Industry Rebounds

by Sapna Bagaria

Stocks in the hospital industry look set to grow on the back of higher patient admissions.

Ensign Group's (ENSG) Q2 Earnings In Line, Increase Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) Q2 results gain from higher revenues, cost management, and better census and managed care skilled mix across its portfolio.

Molina Healthcare (MOH) Misses on Q2 Earnings, Hikes '21 View

by Zacks Equity Research

Molina Healthcare's (MOH) Q2 earnings suffer escalating expenses. However, the same was partly offset by improved revenues and better membership.